Requires the Department of Veterans Affairs, working with the CDC, to study how often bile duct cancer (cholangiocarcinoma) occurs among Vietnam-era veterans who served in the Vietnam theater and to report the findings to Congress.

Official title: Vietnam Veterans Liver Fluke Cancer Study Act

Next stop Senate: awaiting action

Timeline each lane is a chamber; dates pull from congress.gov actions

House

Introduced 21-JAN-2025

Referred 21-JAN-2025

Passed 07-APR-2025

Senate

Received 08-APR-2025

Key points

Requires the VA Secretary to begin an epidemiological study within 120 days of enactment, using VA Central Cancer Registry and National Program of Cancer Registries data
Compares cholangiocarcinoma incidence in covered veterans with incidence among U.S. residents, broken out by age, gender, race, ethnicity, and geographic location at diagnosis
Requires an initial report to Congress within one year after the study is completed, with recommended administrative or legislative actions, followed by periodic updates
Extends the date in 38 U.S.C. 5503(d)(7) on the limitation of pension payments from November 30, 2031 to December 31, 2031

AI-generated from the Referred in Senate text of 08-APR-2025 · verify · report an error

Official CRS summary

Covers an older version. The newest CRS summary describes the bill as of "Introduced in House" (21-JAN-2025); the text has changed since (Engrossed in House, 07-APR-2025).

CRS is the Library of Congress's nonpartisan research office. Read it on congress.gov

Committee referrals (3)

Policy area

Armed Forces and National Security

Sponsor Nick LaLota (R-NY) Cosponsors · 8

■ 5 D■ 3 R

5 Democrats

3 Republicans

congress.gov page Referred in Senate (08-APR-2025) Engrossed in House (07-APR-2025) Introduced in House (21-JAN-2025) House: On motion to suspend the rules and pass the bill, as..., 411-0, 07-APR-2025